Am J Hematol
- ROTH A, Barcellini W, Ademokun C, Jang J, et al
Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase
2 Basket Clinical Trial.
Am J Hematol. 2026;101:242-254.
- BARCELOS GT, Peixoto T, Alvir J, Lin J, et al
Economic Burden of Sickle Cell Disease: A Retrospective Study of Pediatric and
Adult Individuals With Medicaid Coverage From 2016 to 2020.
Am J Hematol. 2026;101:269-280.
- HUANG L, Wang Q, Li HL, Peng W, et al
Flu/Cy Plus PTCy Conditioning Regimen in Haplo-HSCT of Severe Aplastic Anemia.
Am J Hematol. 2026 Jan 3. doi: 10.1002/ajh.70176.
- IDRISS S, Hoogewijs D, Girodon F, Gardie B, et al
Erythropoietin Expression and Regulation: Piecing Together Known Mechanisms and
Emerging Insights.
Am J Hematol. 2026 Jan 3. doi: 10.1002/ajh.70173.
- ZHANG L, Li R, Liang Q, Li W, et al
Hetrombopag Added to Cyclosporine as the First-Line Treatment for Patients With
Non-Severe Aplastic Anemia: A Phase 2 Multicenter Trial.
Am J Hematol. 2026 Jan 5. doi: 10.1002/ajh.70183.
- BENOTTI PN, Wood GC, Kaberi-Otarod J, Still CD, et al
Preoperative Iron Status and the Risk of Severe Postoperative Anemia After
Metabolic and Bariatric Surgery.
Am J Hematol. 2026 Jan 6. doi: 10.1002/ajh.70191.
- LECORNEC N, de Fontbrune FS, Forcade E, Garcon L, et al
Hematologic Landscape of Adult Patients With Diamond-Blackfan Anemia Syndrome.
Am J Hematol. 2026 Jan 7. doi: 10.1002/ajh.70197.
- FORNI GL, Stampone E, Pinto VM, Silvestri L, et al
Iron Overload and Anemia in Transferrin Immune Complex Disease, an Overlooked
Monoclonal Gammopathy of Clinical Significance.
Am J Hematol. 2026 Jan 7. doi: 10.1002/ajh.70187.
- TEFFERI A, Abdelmagid M, Palmer JM, Al-Kali A, et al
Post-FDA Approval Experience With Momelotinib in JAK Inhibitor-Naive
Myelofibrosis: Focus on Anemia Response and Treatment-Emergent Nephropathy and
Peripheral Neuropathy.
Am J Hematol. 2026 Jan 8. doi: 10.1002/ajh.70203.
Ann Hematol
- BENITO SF, Abio M, Bardon-Cancho EJ, Nieto JM, et al
Importance of the 3'UTR region in globin synthesis: identification of two novel
HBA1 mutations causing alpha-Thalassemia.
Ann Hematol. 2025;104:6169-6174.
- CHIBUIFE EC, Chisom Adaobi NE, Odini F, Deepika HD, et al
Can platelet to neutrophil ratio (PNR) serve as a viable alternative tool for
monitoring sickle cell disease patients on hydroxyurea in low income countries?
Ann Hematol. 2025;104:6161-6168.
- LIU HL, Huang WT
Hemoglobin suresnes combined with alpha(0)-thalassemia: Diagnostic challenges and
insights from trio-based whole exome sequencing.
Ann Hematol. 2025;104:6391-6394.
- YE C, Zhou X, Wei Y, Zhao Y, et al
A direct multiplex isothermal amplification-reverse dot blot hybridization system
for beta-thalassemia diagnosis.
Ann Hematol. 2025;104:6147-6159.
Haematologica
- DANIELS DE, Hawksworth J, El Hoss S, Oyawoye FO, et al
Erratum to: "Optimizing CRISPR methodology for precise gene editing in the
erythroid cell line BEL-A with high efficiency generation of a sickle cell anemia
model".
Haematologica. 2026;111:436.
JAMA
- KOUGIAS P, Sharath SE, Zhan M, Carson JL, et al
Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac
Risk: The TOP Randomized Clinical Trial.
JAMA. 2025 Nov 8:e2520841. doi: 10.1001/jama.2025.20841.
Kidney Int
-
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic
Kidney Disease (CKD).
Kidney Int. 2026;109.
- BABITT JL, Berns JS, Bozkurt B, Cheung Khedairy RS, et al
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the
Management of Anemia in Chronic Kidney Disease (CKD).
Kidney Int. 2026;109:44-56.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016